Amerigen and Dipharma Announce U.S. FDA Approval for Generic Miglustat 100 mg Capsules

The first generic version of Miglustat is now approved in the U.S. LYNDHURST, N.J. and CHIASSO, Switzerland, April 23rd, 2018 -- (Healthcare Sales & Marketing Network) -- Amerigen Pharmaceuticals Limited ("Amerigen") and Dipharma S.A. ("... Biopharmaceuticals, Generics, FDA, Product Launch Amerigen Pharmaceuticals, Dipharma, Miglustat, Zavesca
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news